Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Cytodyn Inc (Cytodyn), formerly RexRay Corp, is a biotechnology company. It develops and commercializes monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. It is investigating Leronlimab (PRO 140), a fully humanized IgG4 monoclonal antibody directed against CCR5, to treat HIV. The company is also evaluating its pipeline against triple negative breast cancer, solid tumors, graft vs host disease, non-alcoholic steatohepatitis (NASH), coronavirus and auto immune diseases. CytoDyn uses prostate diagnostic test (PCa test) to determine outcomes of patients diagnosed with prostate cancer. It works in collaboration with pharmaceutical and biotechnology companies to develop its products. The company has operational presence in Florida, the US. Cytodyn is headquartered in Vancouver, Washington, the US.

Headquarters United States of America

Address 1111 Main St Ste 660, Vancouver, Washington, 98660-2970


Telephone 1 360 9808524

No of Employees 24

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CYDY (OTC)

EPS XXX

Net Income (2021) XXX -24.3% (2021 vs 2020)

Market Cap* $279.7M

   

   

* As of and is in US$

Explore premium data & analytics

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Cytodyn Inc’s relevant decision makers and contact details.

30+

Clinical Trials

Determine Cytodyn Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

6

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Pipeline Drugs

Identify which of Cytodyn Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Pipeline
Leronlimab
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Financing Agreements In April, the company announced to raise US$1.89 million in equity financing.
2022 Contracts/Agreements In January, the company along with Regnum Corp and SevenScore Pharmaceuticals, LLC entered into a commercialization and license Agreement to commercialize leronlimab (PRO 140) in the U.S. for the treatment of HIV from SevenScore to Regnum.
2021 Regulatory Approval In December, the company submitted a Phase 3, randomized, double blind, placebo controlled trial with the U.S. Food and Drug Administration (FDA) for phase 3 Registrational trial of Leronlimab for Critically Ill COVID-19 population.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Cytodyn Inc F. Hoffmann-La Roche Ltd AbbVie Inc Merck & Co Inc Celgene Corp
Headquarters United States of America Switzerland United States of America United States of America United States of America
City Vancouver Basel North Chicago Whitehouse Station Summit
State/Province Washington - Illinois New Jersey New Jersey
No. of Employees 24 100,920 50,000 68,000 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Tanya Durkee Urbach Chairman Executive Board - -
Scott A. Kelly, M.D. Director; Chief Medical Officer; Head-Business Development Executive Board 2020 50
Seenu Srinivasan, Ph.D. Director - CMC Regulatory Affairs Executive Board 2021 -
Antonio Migliarese President - Interim; Chief Financial Officer Senior Management 2021 -
Nitya Ray, Ph.D. Chief Operating Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer